It also demonstrated reduction of soluble Aβ burden in brain and mitigates formation of amyloid plaques outside the neurons by enhancing the immune response associated with Th2-skewed cytokine response in an APP/PS1 Tg Alzheimer’s disease mouse model. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.